[ad_1]
A phase 3 trial evaluates the safety and efficacy of an investigational bispecific antibody with chemotherapy compared to standard treatment in advanced squamous NSCLC.
Medscape Medical News
[ad_2]
Source link : https://www.medscape.com/viewarticle/trial-supports-ivonescimab-and-chemo-nsclc-survival-2026a1000i5v?src=rss
Author :
Publish date : 2026-06-01 11:50:00
Copyright for syndicated content belongs to the linked Source.